311 related articles for article (PubMed ID: 11589253)
1. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
Crim C; Pierre LN; Daley-Yates PT
Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
3. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
[TBL] [Abstract][Full Text] [Related]
4. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
Lumry WR
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
[TBL] [Abstract][Full Text] [Related]
7. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
Sharpe M; Jarvis B
Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
Daley-Yates PT; Kunka RL; Yin Y; Andrews SM; Callejas S; Ng C
Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
[TBL] [Abstract][Full Text] [Related]
12. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
Onrust SV; Lamb HM
Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
[TBL] [Abstract][Full Text] [Related]
13. Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.
Cowie RL; Giembycz MA; Leigh R
Expert Opin Pharmacother; 2009 Aug; 10(12):2009-14. PubMed ID: 19618993
[TBL] [Abstract][Full Text] [Related]
14. Mometasone furoate is a less specific glucocorticoid than fluticasone propionate.
Austin RJ; Maschera B; Walker A; Fairbairn L; Meldrum E; Farrow SN; Uings IJ
Eur Respir J; 2002 Dec; 20(6):1386-92. PubMed ID: 12503693
[TBL] [Abstract][Full Text] [Related]
15. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
Meltzer EO; Bardelas J; Goldsobel A; Kaiser H
Treat Respir Med; 2005; 4(4):289-96. PubMed ID: 16086602
[TBL] [Abstract][Full Text] [Related]
16. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
[TBL] [Abstract][Full Text] [Related]
17. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
Daley-Yates PT; Richards DH
Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
[TBL] [Abstract][Full Text] [Related]
18. Effect of mometasone furoate by topical application on allergic rhinitis model in rats.
Sugimoto Y; Ishizawa K; Saitou K; Suzuki G; Tarumi T; Nakahara H; Kirino Y; Kamei C
Pharmacology; 2000 Aug; 61(2):91-5. PubMed ID: 10940782
[TBL] [Abstract][Full Text] [Related]
19. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
Blaiss MS
Allergy Asthma Proc; 2011; 32(6):413-8. PubMed ID: 22221434
[TBL] [Abstract][Full Text] [Related]
20. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
Affrime MB; Kosoglou T; Thonoor CM; Flannery BE; Herron JM
Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
